Activities of the Glycylcycline Tigecycline (GAR-936) against 1,924 Recent European Clinical Bacterial Isolates

The in vitro activities of tigecycline against 1,924 clinical isolates were examined. The new glycylcycline exhibited excellent activity against all gram-positive cocci (MICs at which 90% of the isolates tested were inhibited [MIC(90)s], ≤1 μg/ml). In addition, it was also very potent against most m...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Milatovic, D., Schmitz, F.-J., Verhoef, J., Fluit, A. C.
التنسيق: Artigo
اللغة:Inglês
منشور في: American Society for Microbiology 2003
الموضوعات:
Susceptibility
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC149011/
https://ncbi.nlm.nih.gov/pubmed/12499224
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.47.1.400-404.2003
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة